XIFYRM
Live / Applied — Second extension granted (statement of use) (as of 04 Apr 2025)
What this means for you
Not registered yet, but its 31 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98248674
- Mark type
- Stylized text
- Filed
- 31 Oct 2023
- Published for opposition
- 09 Apr 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antirheumatics and antiphlogistics; pain relief medication
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 20 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2025 — SOU EXTENSION 2 GRANTED
- 04 Apr 2025 — SOU EXTENSION 2 FILED
- 04 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2024 — SOU EXTENSION 1 GRANTED
- 10 Jun 2024 — SOU EXTENSION 1 FILED
- 10 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2024 — PUBLISHED FOR OPPOSITION
- 20 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER